Search: onr:"swepub:oai:DiVA.org:uu-112998" >
Inhibition of acety...
-
Darreh-Shori, T.Karolinska Institutet
(author)
Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine
- Article/chapterEnglish2008
Publisher, publication year, extent ...
-
Elsevier BV,2008
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-112998
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-112998URI
-
https://doi.org/10.1016/j.neurobiolaging.2006.09.020DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:116530119URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
The relationship between acetylcholinesterase (AChE) activity in the CSF and brain of patients with Alzheimer's disease (AD) was investigated in 18 mild AD patients following galantamine treatment. The first 3 months of the study had a randomized double-blind placebo-controlled design, during which 12 patients received galantamine (16-24 mg/day) and six patients placebo. This was followed by 9 months Galantamine treatment in all patients. Activities and protein levels of both the "read-through" AChE (AChE-R) and the synaptic (AChE-S) variants in CSF were assessed in parallel together with the regional brain AChE activity by C-11-PMP and PET. The AChE-S inhibition was 30-36% in CSF, which correlated well with the in vivo AChE inhibition in the brain. No significant AChE inhibition was observed in the placebo group. The increased level of the AChE-R protein was 16% higher than that of AChE-S. Both the AChE inhibition and the increased level of AChE-R protein positively correlated with the patient's performance in cognitive tests associated with visuospatial ability and attention. In conclusion, AChE levels in CSF closely mirror in vivo brain AChE levels prior to and after treatment with the cholinesterase inhibitors. A positive cognitive response seems to dependent on the AChE inhibition level, which is balanced by an increased protein level of the AChE-R variant in the patients.
Subject headings and genre
-
Alzheimer's disease
-
acetylcholinesterase
-
positron emission tomography (PET)
-
cerebrospinal fluid (CSF)
-
red blood cells (RBC)
-
galantamine
-
MEDICINE
-
MEDICIN
Added entries (persons, corporate bodies, meetings, titles ...)
-
Kadir, A.
(author)
-
Almkvist, O.Karolinska Institutet
(author)
-
Grut, M.
(author)
-
Wall, AndersUppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi,Enheten för nuklearmedicin och PET(Swepub:uu)andewall
(author)
-
Blomquist, GunnarUppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi(Swepub:uu)gunnblom
(author)
-
Eriksson, B.
(author)
-
Långström, B.
(author)
-
Nordberg, A.Karolinska Institutet
(author)
-
Karolinska InstitutetInstitutionen för onkologi, radiologi och klinisk immunologi
(creator_code:org_t)
Related titles
-
In:Neurobiology of Aging: Elsevier BV29:2, s. 168-1840197-45801558-1497
Internet link
Find in a library
To the university's database